Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation - 1 Jun 2016

Leger Kasey J, Cushing-Haugen Kara, Hansen John A, Fan Wenhong, Leisenring Wendy M, Martin Paul J, Zhao Lue Ping, Chow Eric J

Abstract excerpt

Cardiomyopathy has been recognized as a complication after hematopoietic cell transplantation (HCT). Using a nested case-cohort design, we examined the relationships between demographic, therapeutic, and selected cardiovascular disease risk factors among ≥1-year HCT survivors who developed cardiomyopathy before (n = 43) or after (n = 89) 1 year from HCT as compared to a randomly selected subcohort of survivors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anthracyclines
Share to Cardiomyopathies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus

Share to Hematopoietic Stem Cell Transplantation

Share to Hypertension

Share to Myocardial Ischemia

Share to Predictive Value of Tests

Share to Survivors

Source

Open in PubMed Open full text

Identifiers

PMID: 26968791
DOI: 10.1016/j.bbmt.2016.02.017
PMCID: PMC4977273

Genes

CELF4
HAS3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors.PMID 26968791Read ↗

Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation.Semantic proximity Read ↗

Predictors of Late Cardiovascular Complications in Survivors of Hematopoietic Cell TransplantationSemantic proximity Read ↗

Common genetic predisposition for heart failure and cancer.Semantic proximity Read ↗

Prediction of cardiovascular disease among hematopoietic cell transplantation survivorsSemantic proximity Read ↗

Influence of genetic biomarkers on cardiac diseases in childhood cancer survivors: a systematic review.Semantic proximity Read ↗

Predicting the 10-year risk of cardiomyopathy in long-term survivors of childhood cancer: a report from the St. Jude Lifetime Cohort and the Childhood Cancer Survivor StudySemantic proximity Read ↗

Sudden Cardiac Death (SCD) – risk stratification and prediction with molecular biomarkersSemantic proximity Read ↗

Common variants in HSPB7 and FRMD4B associated with advanced heart failure.Semantic proximity Read ↗

Clonal haematopoiesis is associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy.Semantic proximity Read ↗

Diagnostic yield of genetic testing in heart transplant recipients with prior cardiomyopathy.Semantic proximity Read ↗

Genetic Background in Patients with Cancer Therapy-Induced CardiomyopathySemantic proximity Read ↗

Whole genome sequencing in early onset advanced heart failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.